Skip to main content
Journal cover image

Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium

Publication ,  Conference
Li, L; Xu-Monette, ZY; Ok, CY; Manyam, GC; Visco, C; Tzankov, A; Montes-Moreno, S; Dybkær, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Hsi, ED ...
Published in: Clinical Lymphoma Myeloma and Leukemia
June 2015

Duke Scholars

Published In

Clinical Lymphoma Myeloma and Leukemia

DOI

ISSN

2152-2650

Publication Date

June 2015

Volume

15

Start / End Page

S224 / S224

Publisher

Elsevier BV

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, L., Xu-Monette, Z. Y., Ok, C. Y., Manyam, G. C., Visco, C., Tzankov, A., … Young, K. H. (2015). Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium. In Clinical Lymphoma Myeloma and Leukemia (Vol. 15, pp. S224–S224). Elsevier BV. https://doi.org/10.1016/j.clml.2015.04.101
Li, Ling, Zijun Y. Xu-Monette, Chi Y. Ok, Ganiraju C. Manyam, Carlo Visco, Alexander Tzankov, Santiago Montes-Moreno, et al. “Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium.” In Clinical Lymphoma Myeloma and Leukemia, 15:S224–S224. Elsevier BV, 2015. https://doi.org/10.1016/j.clml.2015.04.101.
Li L, Xu-Monette ZY, Ok CY, Manyam GC, Visco C, Tzankov A, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, Han van Krieken J, Huh J, Ponzoni M, Ferreri AJM, Farnen JP, Møller MB, Piris MA, Winter JN, Medeiros LJ, Young KH. Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium. Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2015. p. S224–S224.
Journal cover image

Published In

Clinical Lymphoma Myeloma and Leukemia

DOI

ISSN

2152-2650

Publication Date

June 2015

Volume

15

Start / End Page

S224 / S224

Publisher

Elsevier BV

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences